Up-Regulation of Cell-Free MicroRNA-1 and MicroRNA-221-3p Levels in Patients with Myocardial Infarction Undergoing Coronary Angiography

Fatemeh Mansouri ^1,2 * , Mir hosein Seyed Mohammadzad ³

Cited by CrossRef: 6

1- Wu Z, Geng J, Bai Y, Qi Y, Chang C, Jiao Y, Guo Z. miR-125b-5p alleviates the damage of myocardial infarction by inhibiting the NFAT2 to reduce F2RL2 expression. Regenerative Medicine. 2023;18(7):543 [Crossref]

2- Mansouri F, Seyed Mohammadzad M. Effects of metformin on changes of miR-19a and miR-221 expression associated with myocardial infarction in patients with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2022;16(9):102602 [Crossref]

3- Skoda R, Nemes A, Bárczi G, Vágó H, Ruzsa Z, Édes I, Oláh A, Kosztin A, Dinya E, Merkely B, Becker D. Survival of Myocardial Infarction Patients with Diabetes Mellitus at the Invasive Era (Results from the Városmajor Myocardial Infarction Registry). JCM. 2023;12(3):917 [Crossref]

4- Liao W, He C, Yang S, Zhou M, Zeng C, Luo M, Yu J, Hu S, Duan Y, Liu Z. Bioinformatics and experimental analyses of glutamate receptor and its targets genes in myocardial and cerebral ischemia. BMC Genomics. 2023;24(1) [Crossref]

5- Fei A, Li L, Li Y, Zhou T, Liu Y. Diagnostic and prognostic value of plasma miR-106a-5p levels in patients with acute heart failure. J Cardiothorac Surg. 2024;19(1) [Crossref]

6- Wang F, An Y, Hao H. MicroRNA-361-5p acts as a biomarker for carotid artery stenosis and promotes vascular smooth muscle cell proliferation and migration. BMC Med Genomics. 2023;16(1) [Crossref]

7- Yu H, Douglas H, Wathieu D, Braun R, Edomwande C, Lightell D, Pham T, Klingenberg N, Bishop S, Khismatullin D, Woods T. Diabetes is accompanied by secretion of pro-atherosclerotic exosomes from vascular smooth muscle cells. Cardiovasc Diabetol. 2023;22(1) [Crossref]